Common genetic variation in calpain-10 gene (CAPN10) and diabetes risk in a multi-ethnic cohort of American postmenopausal women

Human Molecular Genetics

Volumn 16, Issue 23, 2007, Pages 2960-2971

  Song, Yiqing ^a   You, Nai Chieh ^b   Hsu, Yi Hsiang ^c   Sul, James ^b   Wang, Lin ^d   Tinker, Lesley ^e   Eaton, Charles B ^f   Liu, Simin ^a,b,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN 10; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; ASIAN; CASE CONTROL STUDY; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DIABETOGENESIS; ETHNIC DIFFERENCE; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; PACIFIC ISLANDER; POSTMENOPAUSE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; UNITED STATES;

AGED; CALPAIN; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; FEMALE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MENOPAUSE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; UNITED STATES; VARIATION (GENETICS);

EID: 35748969099     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm256     Document Type: Article

References (37)

1. Barroso, I. (2005) Genetics of type 2 diabetes. Diabet. Med., 22, 517-535.
2. Hansen, L. and Pedersen, O. (2005) Genetics of type 2 diabetes mellitus: status and perspectives. Diabetes Obes. Metab., 7, 122-135.
3. Horikawa, Y., Oda, N., Cox, N.J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T.H., Mashima, H., Schwarz, P.E. et al. (2000) Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet., 26, 163-175.
4. Goll, D.E., Thompson, V.F., Li, H., Wei, W. and Cong, J. (2003) The Calpain system. Physiol. Rev., 83, 731-801.
5. Ma, H., Fukiage, C., Kim, Y.H., Duncan, M.K., Reed, N.A., Shih, M., Azuma, M. and Shearer, T.R. (2001) Characterization and expression of calpain 10. A novel ubiquitous calpain with nuclear localization. J. Biol. Chem., 276, 28525-28531.
6. Baier, L.J., Permana, P.A., Yang, X., Pratley, R.E., Hanson, R.L., Shen, G.Q., Mott, D., Knowler, W.C., Cox, N.J., Horikawa, Y. et al. (2000) A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J. Clin. Invest., 106, R69-R73.
7. Hoffstedt, J., Ryden, M., Lofgren, P., Orho-Melander, M., Groop, L. and Arner, P. (2002) Polymorphism in the calpain 10 gene influences glucose metabolism in human fat cells. Diabetologia, 45, 276-282.
8. Sreenan, S.K., Zhou, Y.P., Otani, K., Hansen, P.A., Currie, K.P., Pan, C.Y., Lee, J.P., Ostrega, D.M., Pugh, W., Horikawa, Y. et al. (2001) Calpains play a role in insulin secretion and action. Diabetes 50, 2013-2020.
9. Marshall, C., Hitman, G. and Turner, M. (2003) Calpain-10 regulates insulin secretion. Diabetes, 52, A373.
10. Marshall, C., Hitman, G.A., Partridge, C.J., Clark, A., Ma, H., Shearer, T.R. and Turner, M.D. (2005) Evidence that an isoform of calpain-10 is a regulator of exocytosis in pancreatic beta-cells. Mol. Endocrinol. 19, 213-224.
11. Hoffstedt, J., Naslund, E. and Arner, P. (2002) Calpain-10 gene polymorphism is associated with reduced beta(3)-adrenoceptor function in human fat cells. J. Clin. Endocrinol. Metab., 87, 3362-3367.
12. Tsuchiya, T., Yan, H., Vogelstein, B., Kinzler, K. and Bell, G.I. (2003) Identification of a haplotype associated with the decreased expression of calpain-10 in lymophoblastoid cell lines. Diabetes, 52, A256.
13. Song, Y., Niu, T., Manson, J.E., Kwiatkowski, D.J. and Liu, S. (2004) Are variants in the CAPN10 gene related to risk of type 2 diabetes? A quantitative assessment of population and family-based association studies. Am. J. Hum. Genet., 74, 208-222.
14. Fullerton, S.M., Bartoszewicz, A., Ybazeta, G., Horikawa, Y., Bell, G.I., Kidd, K.K., Cox, N.J., Hudson, R.R. and Di Rienzo, A. (2002) Geographic and haplotype structure of candidate type 2 diabetes susceptibility variants at the calpain-10 locus. Am. J. Hum. Genet. 70, 1096-1106.
15. Vander Molen, J., Frisse, L.M., Fullerton, S.M., Qian, Y., Del Bosque-Plata, L., Hudson, R.R. and Di Rienzo, A. (2005) Population genetics of CAPN10 and GPR35: Implications for the evolution of type 2 diabetes variants. Am. J. Hum. Genet., 76, 548-560.
16. The International HapMap Consortium. (2005) A haplotype map of the human genome. Nature, 437, 1299-1320.
17. Tsuchiya, T., Schwarz, P.E., Bosque-Plata, L.D., Geoffrey Hayes, M., Dina, C., Froguel, P., Wayne Towers, G., Fischer, S., Temelkova-Kurktschiev, T., Rietzsch, H. et al. (2006) Association of the calpain-10 gene with type 2 diabetes in Europeans: Results of pooled and meta-analyses. Mol. Genet. Metab., 89, 174-184.
18. Elbein, S.C., Chu, W., Ren, Q., Hemphill, C., Schay, J., Cox, N.J., Hanis, C.L. and Hasstedt, S.J. (2002) Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians. J. Clin. Endocrinol. Metab., 87, 650-654.
19. de Bakker, P.I., Burtt, N.P., Graham, R.R., Guiducci, C., Yelensky, R., Drake, J.A., Bersaglieri, T., Penney, K.L., Butler, J., Young, S. et al. (2006) Transferability of tag SNPs in genetic association studies in multiple populations. Nat. Genet., 38, 1298-1303.
20. Hinds, D.A., Stuve, L.L., Nilsen, G.B., Halperin, E., Eskin, E., Ballinger, D.G., Frazer, K.A. and Cox, D.R. (2005) Whole-genome patterns of common DNA variation in three human populations. Science, 307, 1072-1079.
21. Cox, N.J., Frigge, M., Nicolae, D.L., Concannon, P., Hanis, C.L., Bell, G.I. and Kong, A. (1999) Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat. Genet., 21, 213-215.
22. Walder, K., McMillan, J., Lapsys, N., Kriketos, A., Trevaskis, J., Civitarese, A., Southon, A., Zimmet, P. and Collier, G. (2002) Calpain 3 gene expression in skeletal muscle is associated with body fat content and measures of insulin resistance. Int. J. Obes. Relat. Metab. Disord., 26, 442-449.
23. Vollmert, C., Hahn, S., Lamina, C., Huth, C., Kolz, M., Schoepfer-Wendels, A., Mann, K., Bongardt, F., Mueller, J.C., Kronenberg, F. et al. (2007) Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians. Am. J. Physiol. Endocrinol. Metab., 292, 836-844.
24. Carlsson, E., Fredriksson, J., Groop, L. and Ridderstrale, M. (2004) Variation in the calpain-10 gene is associated with elevated triglyceride levels and reduced adipose tissue messenger ribonucleic acid expression in obese Swedish subjects. J. Clin. Endocrinol. Metab., 89, 3601-3605.
25. Shima, Y., Nakanishi, K., Odawara, M., Kobayashi, T. and Ohta, H. (2003) Association of the SNP-19 genotype 22 in the calpain-10 gene with elevated body mass index and hemoglobin A1c levels in Japanese. Clin. Chim. Acta, 336, 89-96.
26. Hitman, G.A. and Sudagani, J. (2004) Searching for genes in diabetes and the metabolic syndrome. Int. J. Clin. Pract., 143, 3-8.
27. Anderson, G.L., Manson, J., Wallace, R., Lund, B., Hall, D., Davis, S., Shumaker, S., Wang, C.Y., Stein, E. and Prentice, R.L. (2003) Implementation of the Women's Health Initiative study design. Ann. Epidemiol., 13, S5-S17.
28. The Women's Health Initiative Study Group(1998) Design of the Women's Health Initiative clinical trial and observational study. Control Clin. Trials, 19, 61-109.
29. Hao, K., Liu, S. and Niu, T. (2005) A sparse marker extension tree algorithm for selecting the best set of haplotype tagging single nucleotide polymorphisms. Genet. Epidemiol., 29, 336-352.
30. Wang, L., Liu, S., Niu, T. and Xu, X. (2005) SNPHunter: A bioinformatic software for single nucleotide polymorphism data acquisition and management. BMC Bioinformatics, 6, 60.
31. Gabriel, S.B., Schaffner, S.F., Nguyen, H., Moore, J.M., Roy, J., Blumenstiel, B., Higgins, J., DeFelice, M., Lochner, A., Faggart, M. et al. (2002) The structure of haplotype blocks in the human genome. Science, 296, 2225-2229.
32. Barrett, J.C., Fry, B., Maller, J. and Daly, M.J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263-265.
33. de Bakker, P.I., Yelensky, R., Pe'er, I., Gabriel, S.B., Daly, M.J. and Altshuler, D. (2005) Efficiency and power in genetic association studies. Nat. Genet., 37, 1217-1223.
34. Kraft, P., Cox, D.G., Paynter, R.A., Hunter, D. and De Vivo, I. (2005) Accounting for haplotype uncertainty in matched association studies: A comparison of simple and flexible techniques. Genet. Epidemiol., 28, 261-272.
35. Niu, T., Qin, Z.S., Xu, X. and Liu, J.S. (2002) Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms. Am. J. Hum. Genet., 70, 157-169.
36. Stram, D.O., Leigh Pearce, C., Bretsky, P., Freedman, M., Hirschhorn, J.N., Altshuler, D., Kolonel, L.N., Henderson, B.E. and Thomas, D.C. (2003) Modeling and E-M estimation of haplotype-specific relative risks from genotype data for a case-control study of unrelated individuals. Hum. Hered., 55, 179-190.
37. Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N. and Golani, I. (2001) Controlling the false discovery rate in behavior genetics research. Behav. Brain Res., 125, 279-284.